GSK Grabs Rights to Technology That Gets Drugs Across the Blood-Brain Barrier

GSK is licensing an ABL Bio technology yields bispecific antibodies engineered to leverage a certain transmembrane receptor to cross the blood-brain barrier to treat neurodegeneration. GSK is already partnered with Alector, which has monoclonal antibodies in clinical development for Alzheimer’s disease. The post GSK Grabs Rights to Technology That Gets Drugs Across the Blood-Brain Barrier…

Read More

The Crisis of Elderly Poverty and Its Health Consequences

Poverty significantly impacts the mental and physical health of older adults. Lack of access to care and unaddressed SDOH issues lead to poorly managed chronic conditions, delays in treatment, medication non-adherence, and lower utilization of preventive services. The post The Crisis of Elderly Poverty and Its Health Consequences appeared first on MedCity News.

Read More